Skip to main content
SpringerLink
Log in

Qualitätsgesicherte Anwendung der Sentinellymphknotenbiopsie beim Mammakarzinom

Aktualisierte Empfehlungen

Current guidelines for sentinel lymph node biopsy in breast cancer

  • Zum Thema
  • Published:
Der Gynäkologe Aims and scope

Zusammenfassung

Die Sentinellymphknotenbiopsie stellt ein anerkanntes minimal-invasives Verfahren für die operative Behandlung des frühen Mammakarzinoms dar. Die Methode ersetzt die konventionelle Axilladissektion bei Patientinnen mit kleinem, unifokalem und klinisch nodalnegativem Mammakarzinom. Die Erfolgsraten des Sentinelverfahrens hängen jedoch von vielen Variablen ab. Aus diesem Grund sind Standards für die Indikationsstellung, die technische Durchführung, die histopathologische Aufarbeitung und die therapeutischen Konsequenzen aus den resultierenden Befunden erforderlich. Ein interdisziplinärer Konsensus zur Sentinellymphknotenbiopsie wurde 2003 durch die Deutsche Gesellschaft für Senologie ausgearbeitet. Die Empfehlungen wurden 2004 überarbeitet. Dieser Beitrag fasst die aktualisierten Richtlinien zusammen.

Abstract

The sentinel node biopsy is an acknowledged minimally invasive method for the surgical treatment of the early carcinoma of the breast. This technique replaces the conventional axillary lymph node dissection for patients with a small, unifocal and clinically nodal negative breast cancer. However, the success rate of the sentinel node biopsy depends on many factors. Therefore, standards are necessary for the determination, when sentinel node biopsy is indicated, for the technical implementation, for the histopathological work-up and for the therapeutic conclusions from the resulting findings. In 2003 the German Society of Senology created an interdisciplinary consensus regarding the sentinel node biopsy. The recommendations were revised in 2004. This article summarizes the updated guidelines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Cabanas RM (1977) An approach for the treatment of penile carcinoma. Cancer 39: 456–466

    Article  CAS  PubMed  Google Scholar 

  2. Morton DL, Wen DR, Wong JH et al. (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127: 392–399

    Article  CAS  PubMed  Google Scholar 

  3. Krag DN, Weaver DL, Alex JC et al. (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2: 335–339

    Article  CAS  PubMed  Google Scholar 

  4. Giuliano AE, Kirgan DM, Guenther JM et al. (1994) Lymphatic mapping and lymphadenectomy for breast cancer. Ann Surg 220: 391–398

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bold RJ (2005) Standardization of sentinel lymph node biopsy in breast carcinoma. Cancer 103: 444–446

    Article  PubMed  Google Scholar 

  6. Goldhirsch A, Wood WC, Gelber RD et al. (2003) Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21: 3357–3365

    Article  PubMed  Google Scholar 

  7. American Society of Breast Surgeons (2003) Consensus statement on guidelines for performance of sentinel lymphadenectomy for breast cancer.http://www.breastsurgeons.org

  8. Sobin LH, Wittekind C (2002) TNM classification of malignant tumors, 6th edn. Wiley, New York

  9. Bauerfeind I, Himsl I, Kahlert S et al. (2005) Sentinel-Lymphknotenuntersuchung beim Mammakarzinom. Gynäkologe 38: 236–242

    Google Scholar 

  10. Blanchard DK, Donohue JH, Reynolds C, Grant CS (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138: 482–487

    Article  PubMed  Google Scholar 

  11. Boolbol SK, Borgen PI (2001) Sentinel lymph node biopsy: an American perspective. Breast 10: 287–290

    Article  CAS  PubMed  Google Scholar 

  12. Veronesi U, Paganelli G, Viale G et al. (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349: 546–553

    Article  PubMed  Google Scholar 

  13. Kuehn T, Bembenek A, Büchels H et al. (2003) Sentinel-Node-Biopsie beim Mammakarzinom. Geburtsh Frauenheilk 63: 835–840

    Article  Google Scholar 

  14. Mc Masters KM, Tuttle TM, Carlson DJ et al. (2000) Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18: 2560–2566

    Google Scholar 

  15. Tafra L, Lannin Dr, Swanson MS et al. (2001) Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233: 51–59

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Bergquist L, Frisell J, Liljegren G et al. (2001) Multicenter study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 88: 1644–1648

    Article  Google Scholar 

  17. Kuehn T, Vogl FD, Helms G et al. (2004) Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J Surg Oncol 30: 252–259

    Article  CAS  PubMed  Google Scholar 

  18. Kuehn T, Bembenek A, Decker T et al. (2005) A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regards to quality assurance. Cancer 103: 451–461

    Article  PubMed  Google Scholar 

  19. Baader AA, Tio J, Petru E et al. (2002) T1 breast cancer: identification of patients at low risk of axillary lymph node metastases. Breast Cancer Treat 76: 11–17

    Article  Google Scholar 

  20. Intra M, Veronesi P, Mazzarol G et al. (2003) Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138: 309–313

    Article  PubMed  Google Scholar 

  21. Borgstein PJ, Meijer S, Pijpers RJ et al. (2000) Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg 232: 81–89

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Maza S, Valencia R, Geworski L et al. (2003) Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study. Eur J Nucl Med Mol Imaging 30: 651–656

    Article  PubMed  Google Scholar 

  23. Tanis PJ, Nieweg OE, Valdes Olmos RA et al. (2001) Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 192: 399–409

    Article  CAS  PubMed  Google Scholar 

  24. Pendas S, Jakub J, Giuliano R et al. (2004) The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapie. Cancer Control 11: 231–235

    PubMed  Google Scholar 

  25. Reitsamer R, Peintinger F, Rettenbacher L et al. (2003) Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 84: 63–67

    Article  PubMed  Google Scholar 

  26. McMasters KM, Wong SL, Chao C et al. (2001) Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 234: 292–299

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Sanidas EE, de Bree E, Tsiftsis DD (2003) How many cases are enough for accredetation in sentinel lymph node biopsy in breast cancer? Am J Surg 185: 202–210

    Article  PubMed  Google Scholar 

  28. McCarter MD, Yeung H, Fey J et al. (2001) The breast cancer patient with multiple sentinel nodes: When to stop? J Am Coll Surg 192: 692–697

    Article  CAS  PubMed  Google Scholar 

  29. Nieweg OE, Tanis PJ, Kroon BB (2001) The definition of a sentinel node. Ann Surg Oncol 8: 538–541

    Article  CAS  PubMed  Google Scholar 

  30. Kennedy RJ, Kollias J, Gill PG et al. (2003) Removal of two sentinel nodes accurately stages the axilla in breast cancer. Br J Surg 90: 1349–1353

    Article  CAS  PubMed  Google Scholar 

  31. Cserni G, Amendoeira I, Apostolikas N et al. (2003) Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39: 1654–1667

    Article  CAS  PubMed  Google Scholar 

  32. Neville AM, Prica KN, Gelber RD et al. (1991) Axillary node micrometastasis in breast cancer. Lancet 337: 1110

    Article  CAS  PubMed  Google Scholar 

  33. McGuckin MA, Cummings MC, Walsh MD et al. (1996) Occult axillary node metastases in breast cancer: the detection and prognostic significance. Br J Cancer 73: 88–95

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Schwartz GF, Guiliano AE, Veronesi U et al. (2002) Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma of the breast. Breast J 8: 124–138

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

  1. Klinik für Frauenheilkunde und Geburtshilfe, Universitätsfrauenklinik Schleswig-Holstein, Campus Lübeck, Deutschland

    D. Fischer, C. Altgassen & T. Kühn

  2. Klinik für Frauenheilkunde und Geburtshilfe, Universitätsfrauenklinik Schleswig-Holstein, Ratzeburger Allee 160, 23538, Lübeck, Deutschland

    D. Fischer

Authors
  1. D. Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Altgassen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Kühn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Fischer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fischer, D., Altgassen, C. & Kühn, T. Qualitätsgesicherte Anwendung der Sentinellymphknotenbiopsie beim Mammakarzinom. Gynäkologe 38, 891–898 (2005). https://doi.org/10.1007/s00129-005-1750-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-005-1750-9

Schlüsselwörter

Keywords

Search

Navigation